IMBiologics Corp. (KOSDAQ:493280)
South Korea · Delayed Price · Currency is KRW 47,450
-3,050 (-6.04%)
At close: Apr 9, 2026
IMBiologics Market Cap
IMBiologics has a market cap or net worth of 726.2 billion as of April 10, 2026.
Market Cap
726.20B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
47,450.00
Market Cap Chart
Since March 20, 2026, IMBiologics's market cap has decreased from 1.54T to 726.20B, a decrease of -52.79%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 701.80B | -6.04% |
| Apr 8, 2026 | 746.91B | 15.83% |
| Apr 7, 2026 | 644.86B | -5.93% |
| Apr 6, 2026 | 685.53B | -1.07% |
| Apr 3, 2026 | 692.92B | -4.49% |
| Apr 2, 2026 | 725.46B | -14.99% |
| Apr 1, 2026 | 853.40B | 4.34% |
| Mar 31, 2026 | 817.90B | -15.83% |
| Mar 30, 2026 | 971.72B | -12.28% |
| Mar 27, 2026 | 1.11T | -3.10% |
| Mar 26, 2026 | 1.14T | 7.06% |
| Mar 25, 2026 | 1.07T | -2.43% |
| Mar 24, 2026 | 1.09T | -2.76% |
| Mar 23, 2026 | 1.13T | -26.83% |
| Mar 20, 2026 | 1.54T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 1.49T |
| Qurient | 1.39T |
| JS Link | 1.34T |
| AprilBio | 1.22T |
| Inventage Lab | 852.40B |
| Curocell | 813.61B |
| IntoCell | 593.37B |
| Kanaph Therapeutics | 466.42B |